Human Molecular Genetics Advance Access originally published online on August 22, 2005
Human Molecular Genetics 2005 14(19):2839-2849; doi:10.1093/hmg/ddi316
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A-type lamins are essential for TGF-ß1 induced PP2A to dephosphorylate transcription factors


1Experimental and Molecular Cardiology, Cardiovascular Research Institute Maastricht, 2Department of Molecular Genetics, Research Institute Growth and Development and 3Department of Molecular Cell Biology, Cardiovascular Research Institute Maastricht, University Maastricht, Maastricht, The Netherlands and 4Department of Cardiology, University Hospital Maastricht, Maastricht, The Netherlands and 5School of Biological and Biomedical Sciences, The University of Durham, Durham, UK
* To whom correspondence should be addressed at: Experimental and Molecular Cardiology, Cardiovascular Research Institute Maastricht (CARIM), University Maastricht, P. Debyelaan 25, PO Box 5800, 6202 AZ Maastricht, The Netherlands. Tel: +31 433877097; Fax: +31 433871055; Email: y.pinto{at}cardio.azm.nl
Received June 1, 2005; Revised August 1, 2005; Accepted August 11, 2005
Diseases caused by mutations in lamins A and C (laminopathies) suggest a crucial role for A-type lamins in different cellular processes. Laminopathies mostly affect tissues of mesenchymal origin. As transforming growth factor-ß1 (TGF-ß1) signalling impinges on the retinoblastoma protein (pRB) and SMADs, we tested the hypothesis that lamins modulate cellular responses to TGF-ß1 signalling, via the regulation of these transcription factors in mesenchymal cells. Here, we report that A-type lamins are essential for the inhibition of fibroblast proliferation by TGF-ß1. TGF-ß1 dephosphorylated pRB through PP2A, both of which, we show, are associated with lamin A/C. In addition, lamin A/C modulates the effect of TGF-ß1 on collagen production, a marker of mesenchymal differentiation. Our findings implicate lamin A/C in control of gene activity downstream of TGF-ß1, via nuclear phosphatases such as PP2A. This biological function provides a novel explanation for the observed mesenchymal dysfunction in laminopathies.
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. I. Kim, J. H. Kwak, L. Wang, and M. E. Choi Protein Phosphatase 2A Is a Negative Regulator of Transforming Growth Factor-{beta}1-induced TAK1 Activation in Mesangial Cells J. Biol. Chem., April 18, 2008; 283(16): 10753 - 10763. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dechat, K. Pfleghaar, K. Sengupta, T. Shimi, D. K. Shumaker, L. Solimando, and R. D. Goldman Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin Genes & Dev., April 1, 2008; 22(7): 832 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. V. Cohen, O. Kosti, and C. L. Stewart The nuclear envelope protein MAN1 regulates TGF{beta} signaling and vasculogenesis in the embryonic yolk sac Development, April 1, 2007; 134(7): 1385 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Naetar, S. Hutter, D. Dorner, T. Dechat, B. Korbei, J. Gotzmann, H. Beug, and R. Foisner LAP2{alpha}-binding protein LINT-25 is a novel chromatin-associated protein involved in cell cycle exit J. Cell Sci., March 1, 2007; 120(5): 737 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Spuler, T. Kalbhenn, J. Zabojszcza, F.K.H. van Landeghem, A. Ludtke, K. Wenzel, M. Koehnlein, M. Schuelke, L. Ludemann, and H. H. Schmidt Muscle and nerve pathology in Dunnigan familial partial lipodystrophy Neurology, February 27, 2007; 68(9): 677 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Pekovic, J. Harborth, J. L.V. Broers, F. C.S. Ramaekers, B. van Engelen, M. Lammens, T. von Zglinicki, R. Foisner, C. Hutchison, and E. Markiewicz Nucleoplasmic LAP2{alpha}-lamin A complexes are required to maintain a proliferative state in human fibroblasts J. Cell Biol., January 16, 2007; 176(2): 163 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L.R.M. Verstraeten, J. L.V. Broers, M. A.M. van Steensel, S. Zinn-Justin, F. C.S. Ramaekers, P. M. Steijlen, M. Kamps, H. J.H. Kuijpers, D. Merckx, H. J.M. Smeets, et al. Compound heterozygosity for mutations in LMNA causes a progeria syndrome without prelamin A accumulation Hum. Mol. Genet., August 15, 2006; 15(16): 2509 - 2522. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Nitta, S. A. Jameson, B. A. Kudlow, L. A. Conlan, and B. K. Kennedy Stabilization of the Retinoblastoma Protein by A-Type Nuclear Lamins Is Required for INK4A-Mediated Cell Cycle Arrest. Mol. Cell. Biol., July 1, 2006; 26(14): 5360 - 5372. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. V. Broers, F. C. S. Ramaekers, G. Bonne, R. B. Yaou, and C. J. Hutchison Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev, July 1, 2006; 86(3): 967 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dorner, S. Vlcek, N. Foeger, A. Gajewski, C. Makolm, J. Gotzmann, C. J. Hutchison, and R. Foisner Lamina-associated polypeptide 2{alpha} regulates cell cycle progression and differentiation via the retinoblastoma-E2F pathway. J. Cell Biol., April 10, 2006; 173(1): 83 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Boguslavsky, C. L. Stewart, and H. J. Worman Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy Hum. Mol. Genet., February 15, 2006; 15(4): 653 - 663. [Abstract] [Full Text] [PDF] |
||||








